Apocynum venetum leaf extract attenuates disruption of the blood-brain barrier and upregulation of matrix metalloproteinase-9/-2 in a rat model of cerebral ischemia-reperfusion injury

Neurochemical Research

Volumn 37, Issue 8, 2012, Pages 1820-1828

  Xiang, Jun ^a,b   Lan, Rui ^a   Tang, Yu Ping ^c   Chen, Yi Ping ^a   Cai, Ding Fang ^a  

^a FUDAN UNIVERSITY   (China)

^b SHANGHAI UNIVERSITY OF TRADITIONAL CHINESE MEDICINE   (China)

^c FUDAN UNIVERSITY   (China)

Author keywords

Apocynum venetum leaf extract; Blood brain barrier; Cerebral ischemia reperfusion; Matrix metalloproteinase 9 2

Indexed keywords

APOCYNUM VENETUM EXTRACT; GELATINASE A; GELATINASE B; PLANT EXTRACT; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOCYNUM; APOCYNUM VENETUM; ARTICLE; BLOOD BRAIN BARRIER; BRAIN INFARCTION SIZE; BRAIN ISCHEMIA; CONTROLLED STUDY; DOWN REGULATION; ENZYME ACTIVITY; MALE; MEMBRANE PERMEABILITY; MIDDLE CEREBRAL ARTERY OCCLUSION; MORPHOLOGY; NONHUMAN; PLANT LEAF; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; REPERFUSION INJURY; TRANSMISSION ELECTRON MICROSCOPY; TREATMENT RESPONSE; WATER CONTENT;

ANIMALS; APOCYNUM; BLOOD-BRAIN BARRIER; BRAIN ISCHEMIA; CEREBRAL INFARCTION; DOWN-REGULATION; EVANS BLUE; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASE 9; NEUROPROTECTIVE AGENTS; PLANT EXTRACTS; PLANT LEAVES; RATS; REPERFUSION INJURY;

APOCYNUM VENETUM; RATTUS;

EID: 84864351089     PISSN: 03643190     EISSN: 15736903     Source Type: Journal    
DOI: 10.1007/s11064-012-0796-z     Document Type: Article

References (34)

1. Kwan CY et al (2005) A novel in vitro endothelium-dependent vascular relaxant effect of Apocynum venetum leaf extract. Clin Exp Pharmacol Physiol 32(9):789-795
2. Kim DW et al (2000) Inhibitory effects of an aqueous extract of Apocynum venetum leaves and its constituents on Cu(2+)-induced oxidative modification of low density lipoprotein. Phytother Res 14(7):501-504
3. Grundmann O et al (2009) Kaempferol from the leaves of Apocynum venetum possesses anxiolytic activities in the elevated plus maze test in mice. Phytomedicine 16(4):295-302
4. Grundmann O et al (2007) Anti-anxiety effects of Apocynum venetum L. in the elevated plus maze test. J Ethnopharmacol 110(3):406-411
5. Fattorusso R et al (2006) Traditional Chinese medicines with caspase-inhibitory activity. Phytomedicine 13(1-2):16-22
6. Xiang J et al (2010) Apocynum venetum leaf extract protects rat cortical neurons from injury induced by oxygen and glucose deprivation in vitro. Can J Physiol Pharmacol 88(9):907-917
7. Hawkins BT, Davis TP (2005) The blood-brain barrier/neurovascular unit in health and disease. Pharmacol Rev 57(2):173-185
8. Ballabh P, Braun A, Nedergaard M (2004) The blood-brain barrier: an overview: structure, regulation, and clinical implications. Neurobiol Dis 16(1):1-13
9. Date I et al (2006) Hepatocyte growth factor attenuates cerebral ischemia-induced increase in permeability of the blood-brain barrier and decreases in expression of tight junctional proteins in cerebral vessels. Neurosci Lett 407(2):141-145
10. Qu YZ et al (2009) Astragaloside IV attenuates cerebral ischemia-reperfusion-induced increase in permeability of the bloodbrain barrier in rats. Eur J Pharmacol 606(1-3):137-141
11. Rosenberg GA (1995) Matrix metalloproteinases in brain injury. J Neurotrauma 12(5):833-842
12. Shibayama M et al (1997) Induction of matrix metalloproteinases following brain injury in rats. Acta neurochirurgica 70(Supplement):220-221
13. Lo EH, Wang X, Cuzner ML (2002) Extracellular proteolysis in brain injury and inflammation: role for plasminogen activators and matrix metalloproteinases. J Neurosci Res 69(1):1-9
14. Rosenberg GA, Mun-Bryce S (2004) Matrix metalloproteinases in neuroinflammation and cerebral ischemia. Ernst Schering Res Found Workshop 47:1-16
15. Rosenberg GA (2002) Matrix metalloproteinases in neuroinflammation. Glia 39(3):279-291
16. Butterweck V et al (2001) Antidepressant effects of Apocynum venetum leaves in a forced swimming test. Biol Pharm Bull 24(7):848-851
17. Longa EZ et al (1989) Reversible middle cerebral artery occlusion without craniectomy in rats. Stroke 20(1):84-91
18. Ohsawa I et al (2007) Hydrogen acts as a therapeutic antioxidant by selectively reducing cytotoxic oxygen radicals. Nat Med 13(6):688-694
19. Wang Z et al (2011) Valproic acid attenuates blood-brain barrier disruption in a rat model of transient focal cerebral ischemia: the roles of HDAC and MMP-9 inhibition. J Cereb Blood Flow Metab 31(1):52-57
20. Zhou J et al (2011) Thrombopoietin protects the brain and improves sensorimotor functions: reduction of stroke-induced MMP-9 upregulation and blood-brain barrier injury. J Cereb Blood Flow Metab 31(3):924-933
21. Yagi K et al (2009) Edaravone, a free radical scavenger, inhibits MMP-9-related brain hemorrhage in rats treated with tissue plasminogen activator. Stroke 40(2):626-631
22. Rosell A et al (2008) MMP-9-positive neutrophil infiltration is associated to blood-brain barrier breakdown and basal lamina type IV collagen degradation during hemorrhagic transformation after human ischemic stroke. Stroke 39(4):1121-1126
23. Heo JH, Han SW, Lee SK (2005) Free radicals as triggers of brain edema formation after stroke. Free Radic Biol Med 39(1):51-70
24. Jin R, Yang G, Li G (2010) Molecular insights and therapeutic targets for blood-brain barrier disruption in ischemic stroke: critical role of matrix metalloproteinases and tissue-type plasminogen activator. Neurobiol Dis 38(3):376-385
25. Mayhan WG (2000) Nitric oxide donor-induced increase in permeability of the blood-brain barrier. Brain Res 866(1-2):101-108
26. Abbott NJ (2000) Inflammatory mediators and modulation of blood-brain barrier permeability. Cell Mol Neurobiol 20(2):131-147
27. Jian Liu K, Rosenberg GA (2005) Matrix metalloproteinases and free radicals in cerebral ischemia. Free Radic Biol Med 39(1): 71-80
28. Rosell A, Lo EH (2008) Multiphasic roles for matrix metalloproteinases after stroke. Curr Opin Pharmacol 8(1):82-89
29. Yang Y et al (2007) Matrix metalloproteinase-mediated disruption of tight junction proteins in cerebral vessels is reversed by synthetic matrix metalloproteinase inhibitor in focal ischemia in rat. J Cereb Blood Flow Metab 27(4):697-709
30. Heo JH et al (1999) Matrix metalloproteinases increase very early during experimental focal cerebral ischemia. J Cereb Blood Flow Metab 19(6):624-633
31. Asahi M et al (2001) Effects of matrix metalloproteinase-9 gene knock-out on the proteolysis of blood-brain barrier and white matter components after cerebral ischemia. J Neurosci 21(19): 7724-7732
32. Rodriguez-Ramiro I et al (2011) Procyanidin B2 and a cocoa polyphenolic extract inhibit acrylamide-induced apoptosis in human Caco-2 cells by preventing oxidative stress and activation of JNK pathway. J Nutr Biochem 22(12):1186-1194
33. Higdon JV, Frei B (2003) Tea catechins and polyphenols: health effects, metabolism, and antioxidant functions. Crit Rev Food Sci Nutr 43(1):89-143
34. Cuevas E et al (2009) Antioxidant effects of epicatechin on the hippocampal toxicity caused by amyloid-beta 25-35 in rats. Eur J Pharmacol 616(1-3):122-127